Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd.’s Net Profit Dropped 20.5% in First Three Quarters of 2022

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. (通化金马药业集团股份有限公司) (000766.SZ) reported a net profit of 11.7 million yuan in the first three quarters of 2022, down 20.5% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, down 6.4% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 48.6%.